Consistent with the aforementioned results, compared with patients with hs-cTnI under 5 ng/L, those with hs-cTnI ≥ 5 ng/L presented significantly lower lymphocyte count and SpO2, higher CRP and incidence of bilateral pneumonia, and longer hospital length of stay (all Pbonferroni < 0.05). The gene discussed is TNNI3; the disease is susceptibility to pneumonia measurement.